Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The impact of continuous glucose monitoring on diabetes distress among high-risk adolescents and young adults: Secondary outcomes from a pilot randomized controlled trial.
Journal: Psychology, health & medicine
Published: October 29, 2025
Youth-onset type 2 diabetes: Advances, treatments, and challenges in prevention.
Journal: Journal of clinical lipidology
Published: January 31, 2025
CRISPLD2, a novel insulin-sensitizing adipokine that alters adipocyte size.
Journal: Obesity (Silver Spring, Md.)
Published: January 20, 2025
Real-Time Continuous Glucose Monitoring Reduced Costly Diabetes-Related Events in Adolescents and Young Adults despite Lack of Short-Term Reduction in Hemoglobin A1c.
Journal: Pediatric diabetes
Published: January 18, 2023
Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry.
Journal: Diabetes care
Published: January 12, 2021
Inhibition of γ-secretase in adipocytes leads to altered IL-6 secretion and adipose inflammation.
Journal: Adipocyte
Published: July 01, 2020
Weight Loss Results in Increased Expression of Anti-Inflammatory Protein CRISPLD2 in Mouse Adipose Tissue.
Journal: Obesity (Silver Spring, Md.)
Published: June 15, 2019
Macrophage-Derived microRNA-155 Increases in Obesity and Influences Adipocyte Metabolism by Targeting Peroxisome Proliferator-Activated Receptor Gamma.
Journal: Obesity (Silver Spring, Md.)
Published: February 22, 2019
Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study.
Journal: The Journal of clinical endocrinology and metabolism
Published: December 21, 2018
Adipocyte-specific blockade of gamma-secretase, but not inhibition of Notch activity, reduces adipose insulin sensitivity.
Journal: Molecular metabolism
Published: November 11, 2015
Last Updated: 09/26/2026